Episode 74: EMR in Ophthalmology, RPE Tears, Steroids for DME, Journal Club

salz kuriyan.png

Dr. David Salz of The Eye Specialists in Bridgewater, NJ and Dr. Ajay Kuriyan of the University of Rochester join for a journal club about three recent articles:

[1:10] Introduction

[1:34] Any thoughts on how Lampalizumab did not meet its Phase III endpoint?

[4:07] Overview of “Time Requirements for Electronic Health Record Use in an Academic Ophthalmology Center” article.

[5:48] Any thoughts on this paper and its conclusions?

[8:00] How does this study apply specifically to the field of retina?

[10:50] Discussion of time spent using EMR for the “simple” versus “complex” patient.

[12:10] Overview of “Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.”

[16:00] Discussion of sample size and ideal study design.

[18:27] Summary of “Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.”

[20:20] Any reactions to the results of this study?

[23:12] Discussion of when to switch from Anti-VEGF therapy when the patient is not responding.

[25:48] Conclusion

Jayanth SridharComment